Diabetes
From the Journals
RYGB tops sleeve gastrectomy in long-term outcomes for diabetes
New findings could help patients, clinicians, and policy makers in making informed decisions about which procedure is best suited to patients’...
From the Journals
Putting diabetes tools ‘in the pocket’ improves HbA1c control
Patients with greater clinical need benefited most from having mobile access to a portal housing diabetes-management tools.
From the Journals
Frequent tooth brushing may reduce diabetes risk
Presence of periodontal disease and an increased number of missing teeth may be augmenting factors.
News
Arsenic levels in infant rice cereal are down
Seventy-six percent of samples of infant rice cereal tested in 2018 had levels of arsenic at or below 100 parts per billion.
From the Journals
What are the most prescribed medications for type 2 diabetes?
Empagliflozin and dulaglutide were the most-prescribed drugs in their respective classes for treating type 2 diabetes over 5 years.
News
Testing lab asks FDA to recall NDMA-tainted metformin
Some samples were found to have more than 10 times the safe daily limit for the impurity.
From the Journals
MACE benefits with dapagliflozin improve with disease duration
Findings suggest treatment with the SGLT-2 inhibitor should be initiated early in some high-risk patients.
From the Journals
Latent diabetes warrants earlier, tighter glycemic control
Microvascular risks in adults with latent autoimmune diabetes increase with longer disease duration.
From the Journals
Glucocorticoid use linked to mortality in RA with diabetes
Results strengthen case for treating to target, especially in more vulnerable populations.
Latest News
In gestational diabetes, early postpartum glucose testing is a winner
GRAPEVINE, TEX. – Inpatient postpartum testing captured 99 of 100 patients without sacrificing accuracy.
News
Dulaglutide OK for primary, secondary CV risk reduction in U.S.
This marks the first time a GLP-1 receptor agonist for type 2 diabetes has been approved for primary prevention of CV events.